Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors

Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors

US Patent 6696449 · Granted Feb 24, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Deuterated MK2 pathway inhibitors and methods of using the same2025
Methods of synthesizing substituted pyridinone-pyridinyl compounds2025
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2025
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (P2024
Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for bor2024
Cancer treatments using combinations of CDK and ERK inhibitors2024
Phenylalanine small organic compounds to directly modulate PCSK9 protein activit2024
Composition and methods of use of tetrahydroisoquinoline small molecules to bind2024
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulator2024
Compounds for binding proprotein convertase subtilisin/kexin type 92024
Anti-CD276 antibodies (B7H3)2023
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions2023